Diagnosis of unknown primary cancer based on molecular techniques may influence therapeutic approach and improve survival

• Autores: Blanca Homet Moreno, Ricardo Hitt, Ismael Ghanem Cañete, Hernán Cortés-Funes
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 12, Nº. 8, 2010, págs. 574-575
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Unknown primary cancer (UPC) is a common clinical syndrome classically associated with a poor prognosis. Pathological examination including immunuohistochemistry continues to be essential in tumour origin characterization, althoug in many cases primary tumour site remains unknown. Gene expression based analysis may offer important diagnostic information that could lead to therapeutic decissions.